43 results
8-K
EX-99.1
SRZN
Surrozen Inc
1 Apr 24
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
8:52am
hepatitis. We look forward to presenting the encouraging Phase 1a data at an upcoming medical conference - the first clinical data for this innovative
424B3
SRZN
Surrozen Inc
8 Nov 23
Prospectus supplement
4:27pm
innovative payment and service delivery models to lower Medicare and Medicaid spending; and
implementation of the federal physician payment transparency
424B3
72dykzp6
9 Aug 23
Prospectus supplement
4:39pm
8-K
EX-99.1
w04c1r
9 Aug 23
Surrozen Provides Second Quarter 2023 Financial Results
4:16pm
424B3
lxdw6eyqbm
10 May 23
Prospectus supplement
4:47pm
8-K
EX-99.1
1gie 2z9hu4i2
10 May 23
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates
4:14pm
424B3
y9jw3tuvhczfe4ftd
7 Apr 23
Prospectus supplement
5:20pm
POS AM
6e16snfz8mwuupgtc9y
31 Mar 23
Prospectus update (post-effective amendment)
9:09am
424B3
4k0mjb h5
5 Apr 22
Prospectus supplement
4:43pm
424B3
mpn1o 3tfrsxp
30 Mar 22
Prospectus supplement
9:13pm
POS AM
kstkifj pau6
28 Mar 22
Prospectus update (post-effective amendment)
9:34pm
424B3
gvfbdnq
16 Nov 21
Prospectus supplement
3:04pm